01181nas a2200397   4500000000100000000000100001000000100002008004100003653001100044653003200055653001900087653004600106653002900152653001800181653003000199653004200229653006000271653001300331653001900344653002100363653003200384653002400416100001400440700001200454700001500466700001400481700001400495700001400509700002100523700001600544245015800560250001500718300001200733490000700745020003100752       2022                            d10aHumans10aMirtazapine/adverse effects10aCohort Studies10aVenlafaxine Hydrochloride/therapeutic use10a*Depression/drug therapy10aAmitriptyline10aElectronic Health Records10aAntidepressive Agents/therapeutic use10aSelective Serotonin Reuptake Inhibitors/therapeutic use10a*Suicide10aUnited Kingdom10aadult psychiatry10adepression & mood disorders10asuicide & self-harm1 aR. Joseph1 aR. Jack1 aR. Morriss1 aR. Knaggs1 aD. Butler1 aC. Hollis1 aJ. Hippisley-Cox1 aC. Coupland00aAssociation between mirtazapine use and serious self-harm in people with depression: an active comparator cohort study using UK electronic health records  a2022/03/06  a169-1760 v25  a1362-0347 (Print)1362-0347